Literature DB >> 7031500

Effect of artificial pancreas treatment on peripheral nerve function in diabetes.

F J Service, J R Daube, P C O'Brien, P J Dyck.   

Abstract

To determine whether the complete correction of hyperglycemia of diabetes can rapidly improve abnormal peripheral nerve function, eight hyperglycemic insulin-requiring diabetics underwent 3 days of glucose control with an artificial endocrine pancreas, the BIOSTATOR Glucose Controller. Comparison of neurologic assessment before and after BIOSTATOR treatment showed improvement only in ulnar sensory conduction velocity (+ 3.2 +/- 1.4 meters per second, p less than 0.032) and no significant changes in 24 other nerve conduction measurements, computer-assisted examination, and scored neurologic assessment. Any significant beneficial effect on nerve function resulting from correction of hyperglycemia probably requires more than 3 days to be manifested.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031500     DOI: 10.1212/wnl.31.11.1375

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy.

Authors:  F J Service; R A Rizza; J R Daube; P C O'Brien; P J Dyck
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

2.  Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; K Wiefels; K Dannehl; F A Gries
Journal:  Klin Wochenschr       Date:  1988-05-02

3.  Thermal discrimination thresholds in normal subjects and in patients with diabetic neuropathy.

Authors:  F W Bertelsmann; J J Heimans; E J Weber; E A van der Veen; J A Schouten
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

4.  Effect of plasma glucose control by continuous subcutaneous insulin infusion on nerve conduction.

Authors:  P M Bell; B Sawhney; J R Hayes; D R Hadden
Journal:  Ir J Med Sci       Date:  1985-10       Impact factor: 1.568

5.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

6.  Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Authors:  Catherine L Martin; James Albers; William H Herman; Patricia Cleary; Barbara Waberski; Douglas A Greene; Martin J Stevens; Eva L Feldman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

7.  Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.

Authors:  James W Albers; William H Herman; Rodica Pop-Busui; Eva L Feldman; Catherine L Martin; Patricia A Cleary; Barbara H Waberski; John M Lachin
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

8.  Peripheral nerve abnormalities in newly-diagnosed diabetic children.

Authors:  G Comi; N Canal; L Lozza; L Beccaria; F Meschi; R Vanini; A F D'Arcais; G Chiumello
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

Review 9.  Diabetic neuropathy in elderly patients. What can be done?

Authors:  J Belmin; P Valensi
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.